Relationship between Lectin-like oxidized low-density lipoprotein receptor 1 expression and preoperative echogenic findings of vulnerable carotid plaque

Acta Neurochirurgica

Volumn 152, Issue 4, 2010, Pages 589-595

  Saito, Atsushi ^a,c   Fujimura, Miki ^b,c   Inoue, Takashi ^b,c   Shimizu, Hiroaki ^a,c   Tominaga, Teiji ^a,c  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

^b Konan Hospital   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Carotid plaque; LOX; Matrix metalloproteinase; Oxidized low density lipoprotein

Indexed keywords

GELATINASE A; GELATINASE B; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

AGED; APOPTOSIS; ARTICLE; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NICK END LABELING; PATHOGENESIS; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RISK FACTOR; SMOOTH MUSCLE FIBER;

AGED; APOPTOSIS; CAROTID ARTERY THROMBOSIS; CAROTID ARTERY, INTERNAL; CAROTID STENOSIS; DISEASE PROGRESSION; ENDARTERECTOMY, CAROTID; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IN SITU NICK-END LABELING; LIPOPROTEINS, LDL; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; PROGNOSIS; SCAVENGER RECEPTORS, CLASS E; TISSUE INHIBITOR OF METALLOPROTEINASE-2; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 77953022048     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-009-0573-1     Document Type: Article

References (17)

1. Alverez B, Ruiz C, Chacon P, Alverez-Sabin J, Matas M (2004) Serum values of metalloproteinase-2 and metalloproteinase-9 as related to unstable plaque and inflammatory cells in patients with greater than 70% carotid artery stenosis. J Vasc Surg 40:469-475.
2. Chen XP, Zhang TT, Du GH (2007) Lectin-like oxidized lowdensity lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis? Cardiovasc Drug Rev 25:146-161.
3. Cominacini L, Pasini AF, Garbin U (2000) Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem 27:12633-12638.
4. Gails ZS, Sukhova GK, Lark MW, Libby P (1994) Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493-2503.
5. Gimbrone MA Jr, Cybulsky MI, Kume N, Collins T, Resnick N (1995) Vascular endothelium: an integrator of pathophysiological stimuli in atherogenesis. Ann NY Acad Sci 748:122-132.
6. Gronholdt ML, Nordestgaard BG, Schroeder TV (2001) Ultrasound echolucent carotid plaques predict future strokes. Circulation 104:68-73.
7. Honda M, Kitagawa N, Tsutsumi K (2006) High-resolution magnetic resonance imaging for detection of carotid plaques. Neurosurgery 58:338-346.
8. Ingueneau C, Huynh-DoU TJC, Negre-Salvayre A, Salvayre R, Vindis C (2008) Caveolin-1 sensitizes vascular smooth muscle cells to mildly oxidized LDL-induced apoptosis. Biochem Biophys Res Comm 369:889-893.
9. Ishino S, Mukai T, Kuge Y, Kume N, Ogawa M, Takai N, Kamihashi J, Shiomi M, Minami M, Kita T, Saji H (2008) Targeting of lectinlike oxidized low-density lipoprotein receptor 1 (LOX-1) with 99mTc-labeled anti-LOX-1 antibody: potential agent for imaging of vulnerable plaque. J Nuc Med 49:1677-1685.
10. Kataoka H, Kume N, Miyamoto S, Minami M, Moriwaki H, Murase T, Sawamura M, Masaki T, Hashimoto N, Kita T (1999) Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 99:3111-3117.
11. Li DY, Chen HJ, Staples ED, Ozaki K, Annex B, Singh BK, Vermani R, Mehta JL (2002) Oxidized low-density lipoprotein receptor LOX-1 and apoptosis in human atherosclerotic lesions. J Cardiovasc Pharmacol Ther 7:147-153.
12. Li L, Renier G (2009) The oral anti-diabetic agent, gliclazide, inhibits oxidized LDL-mediated LOX-1 expression, metalloproteinase-9 secretion and apoptosis in human aortic endothelial cells. Atherosclerosis 204:40-46.
13. O'Brien KD, Allen MD, McDonald TO, Chait A, Harlan JM, Fishbein D (1993) Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques: implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 92:945-951.
14. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature 362:801-809.
15. Ruberg FL, Leopold JA (2002) Atherothrombosis: plaque instability and thrombogenesis. Prog Cardiovasc Dis 44:381-394.
16. Sawamura T, Kume N, Aoyama T, Moriwaki H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita T, Masaki T (1997) A novel receptor for oxidized low-density lipoprotein. Nature 386:73-77.
17. Witztum JL, Steinberg D (1991) Role of oxidized low density lipoprotein in atherosclerosis. J Clin Invest 88:1785-1792.